Difficulty: Medium
Average Score: 64%
Practice
Ipratropium bromide is principally effective in
Correct answer
C
Rationale
Ipratropium bromide is principally effective in COPD (Chronic Obstructive Pulmonary Disease) because it is an anticholinergic bronchodilator that works by blocking muscarinic receptors in the airways, leading to relaxation of smooth muscles and dilation of the airways. COPD is characterized by airflow limitation and is commonly treated with bronchodilators like ipratropium bromide to improve breathing.
Option A, Asthma, is incorrect because while ipratropium bromide can be used in asthma exacerbations, it is not considered a first-line treatment for asthma. Inhaled corticosteroids and beta-agonists are more commonly used in asthma management.
Option B, Bronchitis, is also incorrect because bronchitis is an inflammatory condition of the bronchial tubes, often caused by viral infections. While bronchodilators like ipratropium bromide can provide symptomatic relief in acute bronchitis, they are not a primary treatment for the condition.
Option D, All of the above, is incorrect because ipratropium bromide is not typically used as a first-line treatment for asthma or bronchitis. It is primarily indicated for COPD due to its mechanism of action and effectiveness in managing the symptoms of this condition.
In an educational context, understanding the specific indications for drugs like ipratropium bromide is crucial for healthcare professionals to make informed decisions in patient care. Knowing the mechanisms of action, common uses, and contraindications of medications is essential for safe and effective pharmacological management of various conditions.
Option A, Asthma, is incorrect because while ipratropium bromide can be used in asthma exacerbations, it is not considered a first-line treatment for asthma. Inhaled corticosteroids and beta-agonists are more commonly used in asthma management.
Option B, Bronchitis, is also incorrect because bronchitis is an inflammatory condition of the bronchial tubes, often caused by viral infections. While bronchodilators like ipratropium bromide can provide symptomatic relief in acute bronchitis, they are not a primary treatment for the condition.
Option D, All of the above, is incorrect because ipratropium bromide is not typically used as a first-line treatment for asthma or bronchitis. It is primarily indicated for COPD due to its mechanism of action and effectiveness in managing the symptoms of this condition.
In an educational context, understanding the specific indications for drugs like ipratropium bromide is crucial for healthcare professionals to make informed decisions in patient care. Knowing the mechanisms of action, common uses, and contraindications of medications is essential for safe and effective pharmacological management of various conditions.